Viewing Study NCT05838066

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:04 PM
Ignite Modification Date: 2026-01-25 @ 2:19 AM
Study NCT ID: NCT05838066
Status: RECRUITING
Last Update Posted: 2025-05-30
First Post: 2023-04-20
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy and Safety of KN026 in Combination With HB1801 in the First-line Treatment of Subjects With HER2-positive Recurrent or Metastatic Breast Cancer.
Sponsor: Shanghai JMT-Bio Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None First-line Treatment of HER2-positive Recurrent or Metastatic Breast Cancer View
Keywords: